跳至主要内容
临床试验/NCT07735156
NCT07735156招募中不适用

Role of Endovascular Management of Pelvic Congestion Syndome

Sohag University1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2026年1月14日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
30
试验地点
1
主要终点
Improvement in pelvic pain after endovascular embolization

研究概览

简要总结

Pelvic congestion syndrome (PCS) is a common cause of chronic pelvic pain in women and is associated with pelvic venous insufficiency. This prospective interventional study aims to evaluate the safety and clinical effectiveness of endovascular embolization in relieving symptoms and improving quality of life in women diagnosed with PCS

详细描述

Pelvic congestion syndrome is characterized by chronic pelvic pain resulting from pelvic venous reflux and varicosities. Endovascular embolization has emerged as a minimally invasive treatment with promising clinical outcomes. This prospective interventional study will evaluate the efficacy and safety of endovascular embolization in female patients with clinically suspected and imaging-confirmed PCS. Patients will undergo clinical assessment, imaging evaluation, and endovascular treatment according to standard institutional protocols. Clinical outcomes will be assessed using pain scores and symptom improvement during follow-up, while procedural success, technical outcomes, and complications will also be recorded

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
17 Years 至 55 Years(Child, Adult)
性别
Female
接受健康志愿者

入选标准

  • Female patients aged 18 years or older.
  • Chronic pelvic pain for more than 6 months.
  • Clinical suspicion of pelvic congestion syndrome.
  • Imaging findings consistent with pelvic congestion syndrome on Doppler ultrasound, CT venography, MR venography, or catheter venography.
  • Patients willing to undergo endovascular embolization.
  • Written informed consent obtained

排除标准

  • Pregnancy.
  • Active pelvic inflammatory disease.
  • Known pelvic malignancy.
  • Chronic pelvic pain due to other identifiable causes (e.g., endometriosis, large uterine fibroids).
  • Contraindication to iodinated contrast media.
  • Severe renal impairment.
  • Uncorrectable coagulation disorders.
  • Refusal to participate.

结局指标

主要结局

Improvement in pelvic pain after endovascular embolization

时间窗: 6 months

Change in pelvic pain measured using the Visual Analog Scale (VAS, 0-10), comparing baseline with 6-month follow-up. Unit of Measure: VAS score (0-10)

次要结局

  • Technical success of embolization(during the procedure)
  • Change in quality of life(6 months)
  • Procedure-related complications(up to 30 days after the procedure)
  • Quality of life improvement(6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ahmed Nageh Younis

Senior resident, Radiology department

Sohag University

研究点 (1)

Loading locations...

相似试验